Blood Culture Test Market Share, Size, Trends, Industry Analysis Report, By Product (Software, Instruments), By Technique (Conventional, Automated), By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2023 - 2032

Blood Culture Test Market Share, Size, Trends, Industry Analysis Report, By Product (Software, Instruments), By Technique (Conventional, Automated), By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2023 - 2032

The global blood culture test market size is expected to reach USD 17,605.92 million by 2032, according to a new study by Polaris Market Research. The report “Blood Culture Test Market Share, Size, Trends, Industry Analysis Report, By Product (Software, Instruments), By Technique (Conventional, Automated), By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing need for more sophisticated and accurate diagnostic techniques for identifying infectious diseases like sepsis is expected to contribute significantly to market growth. In response to this demand, numerous companies operating in the market are directing their efforts toward creating cutting-edge tests that can enhance the effectiveness and precision of diagnostic processes as a whole.

As a result, a growing number of manufacturing firms are concentrating their resources on advancing the development of sophisticated diagnostic instruments and consumables, aiming to provide healthcare professionals with improved tools for accurate and timely disease detection. This trend is driven by the continuous pursuit of better diagnostic capabilities and the potential to enhance patient outcomes through early and accurate diagnosis of infectious diseases.

Regulatory bodies are placing a strong emphasis on enforcing stringent guidelines to ensure the quality and accuracy of diagnostic procedures. For instance, a notable example is CLSI's release of new National Blood Culture guidelines in May 2022, aimed at preventing and minimizing blood culture contaminations. These regulatory measures are expected to play a pivotal role in driving market demand. Additionally, the global surge in COVID-19 infections led to a substantial uptick in the utilization of blood culture tests worldwide, particularly impacting the demand for automated instruments.

Consequently, there exists a substantial surge in the requirement for advanced tools capable of detecting bacterial, fungal, and mycobacterial infections, particularly within hospital settings and clinical diagnostic laboratories. Furthermore, as per data unveiled by the World Health Organization in 2023, the global landscape witnesses a distressing reality where 1 in every six individuals afflicted with bacterial meningitis succumbs annually. Notably, the prevalence of bacterial meningitis remains notably high within sub-Saharan Africa.

Blood Culture Test Market Report Highlights

Conventional technique garnered largest share, as this is frequently used option at different end use cases

Consumables held the largest share, owing to rise in adoption of blood culture test across different verticals

Automated systems will grow at the fastest rate, owing to the development of sophisticated technologically advanced systems

APAC will grow at rapid pace, primarily ue to rising cases of infectious diseases, huge patient pool, and improvements in healthcare & pathology infrastructure

The global players include BD, Terumo Corporation, Bruker Corporation, bioMerieux, T2 Biosystems, Luminex Corporation, and Abbott Laboratories

Polaris Market Research has segmented the blood culture test market report based on product, technique, technology, application, end use, and regions:

Blood Culture Test, Product Outlook (Revenue - USD Million, 2019 - 2032)

Consumables

Instruments

Software & Services

Blood Culture Test, Technique Outlook (Revenue - USD Million, 2019 - 2032)

Conventional

Automated

Blood Culture Test, Technology Outlook (Revenue - USD Million, 2019 - 2032)

Culture-based Technology

Molecular Technology

PCR

Microarray

PNA-FISH

Proteomic Technology

Blood Culture Test, Application Outlook (Revenue - USD Million, 2019 - 2032)

Bacterial Infections

Fungal Infections

Mycobacterial Infections

Blood Culture Test, End Use Outlook (Revenue - USD Million, 2019 - 2032)

Hospital Laboratories

Reference Laboratories

Others

Blood Culture Test, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa